NCT07211997View on ClinicalTrials.gov

FebriDx® Pediatric Validation Study

Not yet recruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

November 30, 2026

Conditions
Acute Respiratory Infections (ARIs)
Interventions
DEVICE

FebriDx

Bacterial/Non-Bacterial Point-of-Care Assay that detects the presence of MxA and CRP in fingerstick blood

Trial Locations (5)

15227

PAS Research, Pittsburgh

29407

Tribe, Charleston

29607

Tribe- Parkside Pediatrics, Greenville

33613

PAS Research, Tampa

78539

PAS Research, Edinburg

Sponsors

Lead Sponsor

Lumos Diagnostics
All Listed Sponsors
lead

Lumos Diagnostics

INDUSTRY

NCT07211997 - FebriDx® Pediatric Validation Study | Biotech Hunter | Biotech Hunter